GlassScriptPhysician profile
Jamie Taylor
NPI 1447708649
$1,906.53
in general payments reported to CMS, 2019-2025
13 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $318 · 2022: $621 · 2023: $341 · 2024: $350 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $901 · Education: $66.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $900.96 |
| Education | $66.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,193.40 | 2021-2025 | Symplicity G3, Onyx Frontier, Telescope |
| Janssen Pharmaceuticals, INC | $285.58 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $104.16 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $80.35 | 2024 | Rexulti |
| Genzyme Corporation | $41.47 | 2025 | |
| Glaxosmithkline, LLC. | $38.99 | 2025 | Trelegy Ellipta, Nucala |
| E.R. Squibb & Sons, L.L.C. | $31.51 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $30.61 | 2025 | Winrevair |
| Edwards Lifesciences Corporation | $22.96 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Biohaven Pharmaceutical Holding Company LTD. | $22.95 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.49 | 2021 | |
| Abbvie INC. | $18.09 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $17.97 | 2025 | Opsynvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.